Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease — Stella

Home/GLP1-R-related Disease/

View on ClinicalTrials.gov

Recruiting

Back to GLP1-R-related Disease trials

Trial locations(1 site)

China

Tianjin Medical University General Hospital, Tianjin, Tianjin Municipality

Key details

Sponsor

Tianjin Medical University

Collaborators

Tianjin Medical University General Hospital

Enrollment target

~500 participants

Started

February 2019

Primary completion

November 2027

Age range

18 Years – 80 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.